BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32537008)

  • 21. Novel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).
    Yue MM; Lv K; Meredith SC; Martindale JL; Gorospe M; Schuger L
    J Biol Chem; 2014 Dec; 289(49):33971-83. PubMed ID: 25336651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Jiao Y; Li Y; Fu Z; Hou L; Chen Q; Cai Y; Jiang P; He M; Yang Z
    Dis Markers; 2019; 2019():9037131. PubMed ID: 31781311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.
    Chai RC; Wang N; Chang YZ; Zhang KN; Li JJ; Niu JJ; Wu F; Liu YQ; Wang YZ
    Cancer Cell Int; 2019; 19():155. PubMed ID: 31171919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
    Xing J; Tian Y; Ji W; Wang X
    Medicine (Baltimore); 2020 Feb; 99(9):e19230. PubMed ID: 32118724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
    Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
    J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
    PeerJ; 2019; 7():e7816. PubMed ID: 31608178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
    Zhang Y; Zhang Y; Wang J; Yang J; Yang G
    Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eukaryotic translation initiation factor 3B downregulation inhibits cell proliferation and promotes cell apoptosis through negatively regulating tumor necrosis factor receptor superfamily member 21 in gastric cancer.
    Xiong H; Hu M; Huang H; Gong J; Wu J; Zhang H
    Transl Cancer Res; 2019 Oct; 8(6):2242-2251. PubMed ID: 35116977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.
    Li Y; Jiao Y; Luo Z; Li Y; Liu Y
    Medicine (Baltimore); 2019 Nov; 98(44):e17703. PubMed ID: 31689799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
    Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
    Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
    Chen X; Sun M; Feng W; Chen J; Ji X; Xie M; Huang W; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Front Genet; 2023; 14():1056000. PubMed ID: 36845390
    [No Abstract]   [Full Text] [Related]  

  • 39. Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.
    Feng Y; Wu L
    Int J Clin Exp Pathol; 2020; 13(1):99-106. PubMed ID: 32055278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EIF3B promotes cancer progression in pancreatic cancer.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.